Clinical Trials
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Switching to Potential Reduced Exposure Products in Adult Smokers (JUUL)
- Ages21 years - 77 years
- GenderBoth
- Date12/10/2018
- Lung Cancer
A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
- Date05/11/2022
- Lung Cancer
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
- Date05/13/2016
- Lung Cancer
A Biomarker-directed Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy
- Date02/25/2020
- Lung Cancer
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
- Date04/18/2022
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Effect of Flavors and Nicotine on E-Cigarette Appeal and Use in Regular Tobacco-Product Users
- Ages18 years - 30 years
- GenderBoth
- Date03/17/2021
- Lung Cancer
Determining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer
- Date06/20/2016
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Imaging smoking-induced dopamine release utilizing PET imaging and nicotine patches
- Ages18 years - 55 years
- GenderBoth
- Date11/30/2018
- Tobacco Addiction
The interaction of flavor with nicotine form in adult smokers
- Ages21 years and older
- GenderBoth
- Date01/16/2020
- Lung Cancer
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
- Date01/14/2021